Pattern of the activator inhibitor in carcinoma and renal diseases.
D058186:Acute Kidney Injury / Q000097:blood*; D000933:Antifibrinolytic Agents / Q000097:blood* / Q000494:pharmacology; D001806:Blood Urea Nitrogen; D001943:Breast Neoplasms / Q000097:blood; D002364:Caseins; D002850:Chromatography, Gel; D003404:Creatinine / Q000097:blood; D004789:Enzyme Activation / Q000187:drug effects; D005342:Fibrinolysis / Q000187:drug effects; D006689:Hodgkin Disease / Q000097:blood; D006801:Humans; D007414:Intestinal Neoplasms / Q000097:blood; D007676:Kidney Failure, Chronic / Q000097:blood*; D008259:Macroglobulins / Q000378:metabolism; D008297:Male; D009369:Neoplasms / Q000097:blood*; D010190:Pancreatic Neoplasms / Q000097:blood; D010958:Plasminogen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood; D014511:Uremia / Q000097:blood
D000933:Antifibrinolytic Agents; D002364:Caseins; D008259:Macroglobulins; D010958:Plasminogen; D003404:Creatinine